MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Sensyne Health forms research pact with Royal Wolverhampton NHS Trust

StockMarketWire.com

Clinical technology company Sensyne Health said it had signed a five year non-exclusive research agreement the Royal Wolverhampton NHS Trust.

The trust would receive around 0.9% of Sensyne, brining the total share ownership held by NHS trusts in Sensyne to 12.6%.

Sensyne said the agreement would enable the ethical application of clinical artificial intelligence research to improve patient care and accelerate research into new medicines.

The Wolverhampton trust's dataset covered 700,000 unique patient records from a patient population of about 470,000 people.

At 9:45am: (LON:SENS) Sensyne Health Plc Ord 10p share price was 0p at 119p


Story provided by StockMarketWire.com